Literature DB >> 11231618

Pharmacogenetic applications of the Human Genome project.

S B Liggett.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11231618     DOI： 10.1038/85411

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  Polymorphisms of cardiac presynaptic alpha2C adrenergic receptors: Diverse intragenic variability with haplotype-specific functional effects.

Authors:  Kersten M Small; Jeanne Mialet-Perez; Carrie A Seman; Cheryl T Theiss; Kari M Brown; Stephen B Liggett
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

Review 2.  Current directions in chemotherapy for colorectal cancer.

Authors:  Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

3.  Differential connectivity of gene regulatory networks distinguishes corticosteroid response in asthma.

Authors:  Weiliang Qiu; Feng Guo; Kimberly Glass; Guo Cheng Yuan; John Quackenbush; Xiaobo Zhou; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2017-07-20       Impact factor: 10.793

Review 4.  Implications of pharmacogenetics for individualizing drug treatment and for study design.

Authors:  Christian Meisel; Thomas Gerloff; Julia Kirchheiner; Przemyslaw M Mrozikiewicz; Przemyslaw Niewinski; Jürgen Brockmöller; Ivar Roots
Journal:  J Mol Med (Berl)       Date:  2003-03-15       Impact factor: 4.599

Review 5.  Pharmacogenetic tactics and strategies: implications for paediatrics.

Authors:  W W Weber
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Recognition of T*G mismatched base pairs in DNA by stacked imidazole-containing polyamides: surface plasmon resonance and circular dichroism studies.

Authors:  Eilyn R Lacy; Kari K Cox; W David Wilson; Moses Lee
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

7.  A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.

Authors:  Stephen B Liggett; Jeanne Mialet-Perez; Surai Thaneemit-Chen; Stewart A Weber; Scott M Greene; Danielle Hodne; Bradley Nelson; Jennifer Morrison; Michael J Domanski; Lynne E Wagoner; William T Abraham; Jeffrey L Anderson; John F Carlquist; Heidi J Krause-Steinrauf; Laura C Lazzeroni; J David Port; Philip W Lavori; Michael R Bristow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

8.  Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.

Authors:  Yasuhiro Inoue; Chikao Miki; Hideki Watanabe; Junichiro Hiro; Yuji Toiyama; Eiki Ojima; Hidenori Yanagi; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

9.  A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure.

Authors:  Stephen B Liggett; Sharon Cresci; Reagan J Kelly; Faisal M Syed; Scot J Matkovich; Harvey S Hahn; Abhinav Diwan; Jeffrey S Martini; Li Sparks; Rohan R Parekh; John A Spertus; Walter J Koch; Sharon L R Kardia; Gerald W Dorn
Journal:  Nat Med       Date:  2008-04-20       Impact factor: 53.440

10.  Genetic Vulnerability of GPCRs: A Call to Action.

Authors:  Stephen B Liggett
Journal:  Trends Biochem Sci       Date:  2018-04       Impact factor: 13.807
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.